Schobel Alexander Mark has filed 6 insider transactions across 1 company since March 2024.
Most recent transaction: a tax payment of 9645 shares of Aquestive Therapeutics, Inc. ($AQST) on March 09, 2024.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2024 | Aquestive Therapeutics, Inc. | $AQST | Schobel Alexander Mark | Chief Innovation/Tech Officer | F | Common Stock | 9645 | $4.88 | 980,726.0000 | 0 | 0.97% | 0.00% |
| March 15, 2024 | Aquestive Therapeutics, Inc. | $AQST | Schobel Alexander Mark | Chief Innovation/Tech Officer | S | Common Stock | 50000 | $6.00 | 984,476.0000 | 0 | 4.83% | 0.00% |
| March 8, 2024 | Aquestive Therapeutics, Inc. | $AQST | Schobel Alexander Mark | Chief Innovation/Tech Officer | S | Common Stock | 25000 | $5.19 | 1,040,371.0000 | 0 | 2.35% | 0.00% |
| March 9, 2024 | Aquestive Therapeutics, Inc. | $AQST | Schobel Alexander Mark | Chief Innovation/Tech Officer | F | Common Stock | 5895 | $4.88 | 1,034,476.0000 | 0 | 0.57% | 0.00% |
| March 7, 2024 | Aquestive Therapeutics, Inc. | $AQST | Schobel Alexander Mark | Chief Innovation/Tech Officer | A | Common Stock | 82500 | $0.00 | 1,065,371.0000 | 0 | 8.39% | 0.00% |
| March 7, 2024 | Aquestive Therapeutics, Inc. | $AQST | Schobel Alexander Mark | Chief Innovation/Tech Officer | A | Non-Qualified Stock Option (right to buy) | 41250 | $0.00 | 41,250.0000 | 0 | 9999.99% | 0.00% |